KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Weighted Average) (2016 - 2026)

Edwards Lifesciences has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $584.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 2.16% year-over-year to $584.8 million; the TTM value through Dec 2025 reached $584.8 million, down 2.16%, while the annual FY2025 figure was $584.8 million, 2.16% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $584.8 million at Edwards Lifesciences, roughly flat from $584.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $623.6 million in Q3 2021 and troughed at $584.7 million in Q3 2025.
  • A 5-year average of $607.4 million and a median of $606.9 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.21% in 2021 and later fell 2.6% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $623.3 million in 2021, then decreased by 0.69% to $619.0 million in 2022, then fell by 1.99% to $606.7 million in 2023, then decreased by 1.48% to $597.7 million in 2024, then decreased by 2.16% to $584.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for EW at $584.8 million in Q4 2025, $584.7 million in Q3 2025, and $587.0 million in Q2 2025.